12:21 24/04/2014 Hot Stocks- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), SouFun Holdings Ltd ...
Hot Stocks- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), SouFun Holdings Ltd ...
Techsonian (press release) - 23 minutes ago
Las Vegas, NV - April 24, 2014 - (TechSonian) - Arena Pharmaceuticals, Inc. (ARNA) provided a corporate update and reported financial results for the fourth quarter and fiscal year which ended on December 31, 2013.

19:22 23/04/2014 Stocks Alert: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Idera ...
Stocks Alert: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Idera ...
Market News Call - 17 hours ago
Lakeway, NY - (MARKET NEWS CALL) - 4/23/2014— Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Worth Watching Stocks: Inovio Pharmaceuticals, (INO), Arena Pharmaceuticals ... - Techsonian (press release)

19:56 22/04/2014 Big Movers: MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals ...
Big Movers: MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals ...
Market News Call - Apr 22, 2014
Lakeway, NY - (MARKET NEWS CALL) - 4/22/2014— Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.

13:33 22/04/2014 Healthcare Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Abbott ...
Healthcare Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Abbott ...
Tech News - Apr 22, 2014
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ® (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight management.

16:11 21/04/2014 Arena Pharmaceuticals' Belviq Sales Dip - Why?
Arena Pharmaceuticals' Belviq Sales Dip - Why?
Seeking Alpha - Apr 21, 2014
Belviq, the anti-obesity drug from Arena Pharmaceuticals (ARNA), saw sales fall over 10% last week according to industry tracking services IMS Health and Symphony Health.
Special News Alert: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Incyte ... - Market News Call

18:13 19/04/2014 Hot Biotech Stocks: Arena Pharmaceuticals (NASDAQ:ARNA), Ariad ...
Hot Biotech Stocks: Arena Pharmaceuticals (NASDAQ:ARNA), Ariad ...
Gaining Green - Apr 19, 2014
One of the main reasons, analysts and pundits say, why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has not had success with its FDA-approved weight management drug known as Belviq, is lack of awareness.
Investor's Watch List -Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Incyte ... - Techsonian (press release)

16:11 17/04/2014 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): TV Ads For Belviq Launched
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): TV Ads For Belviq Launched
USTrade Voice - Apr 17, 2014
Dallas, Texas 04/17/2014 (ustradevoice) - One of the main reasons, analysts and pundits say, why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has not had success with its FDA-approved weight management drug known as Belviq, is lack of awareness.
Small Cap Recent Insider Selling: Arena Pharmaceuticals (NASDAQ:ARNA ... - Tech News
Biotech recent insider selling: Arena Pharmaceuticals (NASDAQ:ARNA ... - Gaining Green

18:23 08/04/2014 Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL ...
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL ...
MarketWatch - Apr 8, 2014
Free technical research on ARNA, CELG, PDLI and HEB can be downloaded upon signing up at: http://www.investor-edge.com/905-register On Monday, shares in Arena Pharmaceuticals Inc. gained 2.57% to close the day at $6.38. The stock recorded a ...

15:48 07/04/2014 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): The Future Is Encouraging
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): The Future Is Encouraging
WallStreetPR - Apr 7, 2014
That being the case, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) seems to have come to the realization that unless it takes proactive steps to expand the market share of its anti-obesity drug Belviq, it might as well miss out on a great opportunity.

13:45 31/03/2014 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Expecting Sales to hit $150M this ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Expecting Sales to hit $150M this ...
USTrade Voice - Mar 31, 2014
Dallas, Texas 03/31/2014 (ustradevoice) - Biopharmaceutical Company, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), expects majority of its revenue for the year to come from its flagship drug, Belviq.